Does Wegovy Wear Off Towards the End of the Week?

Step 1: Understanding what happens from the moment you inject

After a weekly Wegovy dose, semaglutide is absorbed slowly through subcutaneous tissue and reaches its peak blood concentration roughly 24 to 72 hours post-injection. During this window, appetite suppression tends to be at its strongest; many people find these the days when eating less feels genuinely effortless rather than forced.

From around day three onwards, levels begin to fall. By day six or seven (the day before your next injection, for most people) the drug's concentration can be less than half its peak value. The body is still being exposed to semaglutide throughout this period, so the medicine is working. But the intensity of its effect on hunger signals is lower, and that is simply pharmacology rather than treatment failure. How semaglutide's activity shifts day to day is worth understanding before drawing conclusions about whether your dose needs changing.

The practical upside of a long half-life is stability over months: no daily dosing, no peaks and crashes in the way a shorter-acting drug might produce. If you are curious about the point in the week when semaglutide's effects begin to taper and why the timing varies between people, that is covered in detail separately. The week-to-week consistency builds as you move through the titration schedule and plasma levels reach what pharmacologists call steady state, after roughly four to five weeks at any given dose.

Step 2: Recognising the "day 6 or 7" experience for what it is

A handful of patterns tend to cluster towards the end of the weekly cycle. Appetite returns more noticeably. Some people report feeling slightly more nauseated on injection day itself, particularly in the earlier weeks when the cycle of peak-to-trough is more pronounced. Others notice mild headache or fatigue. None of these signal that the medicine has stopped working; they signal that levels are at their weekly low.

Keeping your injection pen in a consistent place helps with timing discipline. Many people store theirs in the fridge door and inject on the same evening each week, pairing it with a small routine so the day never quietly slips. Precise injection-day consistency limits how wide the week-to-week trough becomes.

It is worth separating two distinct questions: whether Wegovy wears off towards the end of the weekly cycle and what that actually means for appetite control is one question, and whether it loses effectiveness across months or years of treatment is quite another. Those are different topics. Long-term effectiveness of Wegovy is discussed separately and draws on different evidence.

Step 3: What to do if the dip is genuinely disruptive

For a minority of people, the end-of-week return of hunger is significant enough to affect eating behaviour. The first thing to do is flag it to your prescriber at the next clinical review. Self-adjusting injection timing, splitting doses, or increasing the dose ahead of schedule are all changes that require prescriber input, they are not straightforward fixes, and the Patient Information Leaflet for semaglutide is clear that dosing decisions stay with the clinical team.

In the meantime, a few practical adjustments fall within lifestyle advice rather than medicine management. Prioritising protein and fibre earlier in the week, when appetite is most suppressed, can help. Eating patterns that are less reliant on moment-to-moment hunger signals tend to hold more steadily across the full seven days.

Some people find that as they progress to higher maintenance doses, the trough effect becomes less noticeable. Higher steady-state plasma levels mean even the weekly low is still a meaningful suppressive concentration. If you have questions about how the STEP 1 trial participants experienced appetite control across the treatment period, the clinical evidence behind Wegovy has more detail on what the research actually showed.

Step 4: When the pattern changes unexpectedly

If the end-of-week dip seems to be getting worse rather than settling, or if you notice that even days two and three are no longer producing the appetite suppression you had earlier in treatment, something beyond normal weekly pharmacokinetics may be at play. Factors that can shift this pattern include changes in injection technique, site selection, storage conditions (pens must be kept refrigerated at 2–8°C until first use), or gradual physiological adaptation.

Any meaningful change in how treatment feels should be reviewed clinically. At nume, every repeat order involves a clinical review by a GPhC-registered prescriber before the next supply is issued, so there is a natural, built-in checkpoint for exactly this kind of question. If cost is a factor in whether to continue, a clear breakdown of what private treatment involves is available on the Wegovy cost page. For anything more urgent, the contact page links directly to our aftercare team, available seven days a week.

Check your eligibility for treatment with our prescribers and discuss the titration schedule that suits your situation at the consultation page.